Using a combination of CTCs, CEA, and CA 125, the diagnosis of adenocarcinomas was also more accurate, with a sensitivity of 77.33% (AUCROC = 0.874 vs 0.845, 0.647, Figure S1B). The gene discussed is CEACAM5; the disease is adenocarcinoma.